ProShares Ultra Nasdaq Biotechnology (BIB) Holdings $52.63 -1.57 (-2.90%) As of 12:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Top 100 BIB HoldingsRankCompanyCurrent PriceWeightShares Held1NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AGN/A41.67%5,5772NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NAN/A35.72%4,7803NASDAQ BIO INDEX SWAP BNP PARIBASN/A21.42%2,8674NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONALN/A9.87%1,3215NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NAN/A9.39%1,2576GILDGilead Sciences$107.35+0.6%7.57%40,4227NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALEN/A7.10%9508AMGNAmgen$310.21-1.3%6.98%13,2339VRTXVertex Pharmaceuticals$510.56-0.2%6.78%7,99410REGNRegeneron Pharmaceuticals$653.97-1.1%5.24%4,674 Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 11AZNAstraZeneca$73.70-0.5%3.29%25,19112ALNYAlnylam Pharmaceuticals$287.79-1.0%2.27%5,58213BIIBBiogen$141.01-0.4%1.48%6,30014ARGXargenx$606.80-0.2%1.42%1,39415SNYSanofi$56.00+0.1%1.26%13,02216SMMTSummit Therapeutics$20.30-1.9%1.11%31,89517RPRXRoyalty Pharma$34.00+0.7%1.06%19,21518ITCIIntra-Cellular Therapies$131.71+0.0%1.01%4,58419INSMInsmed$79.13-0.3%1.00%7,73820UTHRUnited Therapeutics$315.70-1.3%1.00%1,93121ILMNIllumina$88.51+0.6%0.99%6,85922MRNAModerna$34.35+0.5%0.97%16,64823BMRNBioMarin Pharmaceutical$71.93-0.1%0.96%8,24324INCYIncyte$62.40-0.6%0.95%8,33325ONCBeigene$252.80-0.2%0.83%1,91626NBIXNeurocrine Biosciences$115.52-0.1%0.82%4,38027VTRSViatris$9.28-0.3%0.79%51,62428EXELExelixis$37.32-1.1%0.76%12,35429MEDPMedpace$328.80-0.5%0.74%1,34830BNTXBioNTech$98.99-1.6%0.71%4,24831ASNDAscendis Pharma A/S$165.26-1.6%0.67%2,60932SRPTSarepta Therapeutics$74.62-2.2%0.67%4,12933PCVXVaxcyte$71.85-2.7%0.67%5,39234JAZZJazz Pharmaceuticals$141.22-0.6%0.61%2,61635HALOHalozyme Therapeutics$64.24+0.3%0.58%5,50836ROIVRoivant Sciences$10.76-0.7%0.56%31,48537MDGLMadrigal Pharmaceuticals$342.79-1.0%0.55%94238TEMTempus AI$58.15-1.4%0.52%6,59239RVMDRevolution Medicines$38.22-2.8%0.48%7,27440BBIOBridgeBio Pharma$37.04-0.5%0.45%8,176Elon Musk is helping print “new gold” (Ad)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.I reveal all of the details here.41AXSMAxsome Therapeutics$122.06-5.5%0.43%2,09542BPMCBlueprint Medicines$92.62-2.8%0.41%2,74443ALKSAlkermes$34.72-0.2%0.40%6,99744GHGuardant Health$46.71-0.1%0.39%5,34345CYTKCytokinetics$44.77-3.9%0.38%5,10146IONSIonis Pharmaceuticals$32.94-1.5%0.38%6,82847KRYSKrystal Biotech$192.15-1.2%0.38%1,24648NUVLNuvalent$75.54-2.1%0.37%2,83549VRNAVerona Pharma$66.33-0.7%0.33%3,20050ADMAADMA Biologics$20.20-0.6%0.32%10,22451PTCTPTC Therapeutics$56.38-1.1%0.31%3,33652ACLXArcellx$71.69-1.1%0.28%2,33753SWTXSpringWorks Therapeutics$47.58-1.9%0.28%3,22054RNAAvidity Biosciences$32.10-3.6%0.27%5,16455CRSPCRISPR Therapeutics$41.73-2.1%0.26%3,69156RAREUltragenyx Pharmaceutical$38.57-2.0%0.26%3,99557PTGXProtagonist Therapeutics$51.55-1.9%0.24%2,57458SRRKScholar Rock$33.51-0.9%0.24%4,05659CRNXCrinetics Pharmaceuticals$35.25-1.9%0.23%4,01260MRUSMerus$47.42-2.8%0.23%2,96461RYTMRhythm Pharmaceuticals$53.86+0.3%0.23%2,65462AKROAkero Therapeutics$44.47-1.4%0.22%3,01863ALVOAlvotech$11.60+0.3%0.22%11,54364APLSApellis Pharmaceuticals$23.86-1.6%0.22%5,38065LEGNLegend Biotech$35.63-1.9%0.22%3,53366ACADACADIA Pharmaceuticals$17.20-0.2%0.21%7,19467IMVTImmunovant$18.41-5.3%0.21%6,35068AMRXAmneal Pharmaceuticals$8.79-1.1%0.20%13,40569XENEXenon Pharmaceuticals$35.57-2.4%0.20%3,30070FOLDAmicus Therapeutics$8.62-0.9%0.19%12,92471EWTXEdgewise Therapeutics$23.31-0.2%0.18%4,09672RXRXRecursion Pharmaceuticals$6.52-4.1%0.18%16,51573VCYTVeracyte$33.03-0.4%0.18%3,35074TWSTTwist Bioscience$43.94-2.2%0.17%2,56675DNLIDenali Therapeutics$14.36-2.7%0.16%6,22576KYMRKymera Therapeutics$32.75-2.8%0.16%2,80577NAMSNewAmsterdam Pharma$23.90-0.4%0.16%3,99578VCELVericel$47.44-1.0%0.16%2,13579BEAMBeam Therapeutics$23.18-3.5%0.15%3,58180IBRXImmunityBio$2.76-3.3%0.15%30,14381LGNDLigand Pharmaceuticals$111.74+0.1%0.15%81882MIRMMirum Pharmaceuticals$46.69-0.7%0.15%2,07783NVCRNovoCure$18.97-4.1%0.15%4,68084ARWRArrowhead Pharmaceuticals$14.92-3.7%0.14%5,38285CGONCG Oncology$27.71-2.9%0.14%2,92386HRMYHarmony Biosciences$33.63-1.8%0.14%2,47087ZLABZai Lab$35.48-0.5%0.14%2,25488AGIOAgios Pharmaceuticals$31.14-3.6%0.13%2,47089APGEApogee Therapeutics$41.03+0.5%0.13%1,94990DVAXDynavax Technologies$13.96+0.8%0.13%5,681Alert: DOGE goes live (Ad)Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.Click here to learn more.91SUPNSupernus Pharmaceuticals$33.46+2.3%0.13%2,38992TARSTarsus Pharmaceuticals$51.53-1.6%0.13%1,65493VERAVera Therapeutics$26.79-1.3%0.13%2,73494ARQTArcutis Biotherapeutics$17.20-0.5%0.12%5,06595BCRXBioCryst Pharmaceuticals$8.00-0.7%0.12%8,95896IDYAIDEAYA Biosciences$18.17-2.3%0.12%3,73997JANXJanux Therapeutics$30.91-2.6%0.12%2,27098TVTXTravere Therapeutics$21.05-1.1%0.12%3,71199CNTACentessa Pharmaceuticals$16.38-1.5%0.11%3,860100IRONDisc Medicine$52.15-2.9%0.11%1,286 Related Companies and Tools Related Companies F/m Emerald Life Sciences Innovation ETF Top Holdings Invesco Nasdaq Biotechnology ETF Top Holdings Horizon Kinetics Medical ETF Top Holdings First Trust Nasdaq Pharmaceuticals ETF Top Holdings JPMorgan Healthcare Leaders ETF Top Holdings Invesco Dorsey Wright Healthcare Momentum ETF Top Holdings ProShares UltraShort Nasdaq Biotechnology Top Holdings Invesco S&P SmallCap Health Care ETF Top Holdings VanEck Biotech ETF Top Holdings VanEck Pharmaceutical ETF Top Holdings This page (NASDAQ:BIB) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
